Entero Therapeutics terminates CEO James Sapirstein, appoints Richard Paolone as interim CEO

GridAI Technologies Corp.

James Sapirstein terminated as CEO without cause effective February 12, 2025.
Richard Paolone appointed interim CEO and Chairman, effective immediately.
Paolone is a Toronto securities lawyer with board seats at multiple public companies.
Paolone ceases to be independent director; Eric Corbett joins audit, governance, and compensation committees.
Paolone's compensation as interim CEO to be determined at a later date.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Richard Joel Paolone

Interim Chief Executive Officer and Chairman of the Board

GRDX · GridAI Technologies Corp.

Effective: 2025-02-12
Filed: February 14, 2025, 6:59 PM ET

On February 12, 2025, Richard Joel Paolone was appointed to serve as Interim Chief Executive Officer of the Company and Chairman of the Board, effective immediately.

Departed

James Sapirstein

Chief Executive Officer

GRDX · GridAI Technologies Corp.

Effective: 2025-02-12
Successor: Richard Joel Paolone
Filed: February 14, 2025, 6:59 PM ET

On February 12, 2025, the Board of Directors (the “Board”) of Entero Therapeutics, Inc. (the “Company”) terminated James Sapirstein as Chief Executive Officer of the Company, without cause, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Richard Joel Paolone was appointed as Interim Chief Executive Officer and Chairman of the Board at GridAI Technologies Corp..

Action: appointed
Role: Interim Chief Executive Officer and Chairman of the Board

Exact text from the filing

On February 12, 2025, Richard Joel Paolone was appointed to serve as Interim Chief Executive Officer of the Company and Chairman of the Board, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

James Sapirstein was terminated as Chief Executive Officer at GridAI Technologies Corp..

Action: terminated
Role: Chief Executive Officer

Exact text from the filing

On February 12, 2025, the Board of Directors (the “Board”) of Entero Therapeutics, Inc. (the “Company”) terminated James Sapirstein as Chief Executive Officer of the Company, without cause, effective immediately.

View on SEC.gov

GridAI Technologies Corp. filing history →

Source: SEC EDGAR

accession 0001104659-25-014165

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.